Rajesh Ambasudhan, PhD

Scientists find evidence that antibody-based treatments in clinical trials for neurodegenerative diseases may trigger an inflammatory response in human brain immune cells, eroding their positive effects.

In experiments on human 'mini-brains,' the drug preserved nerve connections that are lost to Alzheimer’s. The drug is also being evaluated for COVID-19, as it is known to inhibit viral activity.

Scientists report for the first time that cerebral organoids created with cells from Alzheimer’s patients manifest excessive electrical activity just like people who have the disease.

A new study is the first to show precisely how a process in nerve cells called the S-nitrosylation (SNO) reaction may contribute to Parkinson’s disease.